anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Anebulo Pharmaceuticals · conference-presentation

Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides

53 pages · 3 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides

Anebulo Pharmaceuticals · 2022-09
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON
Narrative range 43 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 4 slides 100% 4/4 slides 100% 4/4 slides · 20 hits
— 0/4 slides
75% 3/4 slides
— 0/4 slides
100% 4/4 slides · 7 hits 75% 3/4 slides Agitate (Make it worse) 3 slides 100% 3/3 slides 100% 3/3 slides · 15 hits
— 0/3 slides
66.7% 2/3 slides
— 0/3 slides
100% 3/3 slides · 6 hits 100% 3/3 slides Solution (Provide relief) 36 slides 100% 36/36 slides 100% 36/36 slides · 147 hits
— 0/36 slides
22.2% 8/36 slides 19.4% 7/36 slides 100% 36/36 slides 16.7% 6/36 slides

Slide inventory

53
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
front_matter
Open slide detail
04
transition
Open slide detail
05
transition
Open slide detail
06
establish_context
Open slide detail
07
summarize
Open slide detail
08
transition
Open slide detail
09
frame_problem
Open slide detailBeat · Problem (Identify pain)
10
The chart uses a stacked bar approach to show captured vs. estimated visits, with trend lines indicating growth rates.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
11
establish_context
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
12
The slide uses a circular infographic layout to connect a visual of cannabis products to three distinct risk categories.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
13
present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
14
Uses a before-after visual comparison to explain the mechanism of action.present_solution
Open slide detailBeat · Solution (Provide relief)
15
The slide uses a process flow diagram to illustrate the progression from Part A to Part B.present_framework
Open slide detailBeat · Solution (Provide relief)
16
state_next_steps
Open slide detailBeat · Solution (Provide relief)
17
The slide uses a linear process flow with icons to represent key development milestones.plan_implementation
Open slide detailBeat · Solution (Provide relief)
18
summarize
Open slide detailBeat · Solution (Provide relief)
19
transition
Open slide detailBeat · Solution (Provide relief)
20
summarize
Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done
21
summarize
Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done
22
Clinical trial summary slide.establish_context
Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done
23
The slide uses a process flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.present_framework
Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done
24
The chart displays a time-course study of VAS (Visual Analog Scale) scores for 'feeling high' across three cohorts.analyze_data
Open slide detailBeat · Solution (Provide relief)Loop · Jobs To Be Done
25
VAS = Visual Analog Scale. Data shows a significant reduction in subjective 'high' feeling with ANEB-001 compared to placebo.analyze_data
Open slide detailBeat · Solution (Provide relief)
26
The data shows a significant reduction in the proportion of subjects feeling high when treated with ANEB-001 compared to placebo.analyze_data
Open slide detailBeat · Solution (Provide relief)
27
The chart shows a reduction in body sway for both 50mg and 100mg doses of ANEB-001 compared to placebo.analyze_data
Open slide detailBeat · Solution (Provide relief)
28
The chart displays mean values with 95% confidence intervals. Statistical significance is indicated by asterisks.analyze_data
Open slide detailBeat · Solution (Provide relief)
29
The slide uses a cascading process diagram to illustrate the iterative nature of the study cohorts.present_framework
Open slide detailBeat · Solution (Provide relief)
30
The slide uses a cascading process flow to show how multiple data streams feed into a central analysis and final model.present_framework
Open slide detailBeat · Solution (Provide relief)
31
The slide uses a flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.present_framework
Open slide detailBeat · Solution (Provide relief)
32
The slide uses a process flow diagram to illustrate the clinical trial methodology.present_framework
Open slide detailBeat · Solution (Provide relief)
33
summarize
Open slide detailBeat · Solution (Provide relief)
34
Includes a smaller inset chart comparing current data to prior 50/100 mg dose data.analyze_data
Open slide detailBeat · Solution (Provide relief)
35
Includes a smaller inset chart showing prior 50/100 mg data for comparison.analyze_data
Open slide detailBeat · Solution (Provide relief)
36
Includes a primary chart and a smaller inset chart for comparison.analyze_data
Open slide detailBeat · Solution (Provide relief)
37
Includes a primary chart and a smaller inset chart showing similar data for different dosage levels.analyze_data
Open slide detailBeat · Solution (Provide relief)
38
The chart displays mean values with SEM error bars for various THC doses and ANEB-001 treatment groups.analyze_data
Open slide detailBeat · Solution (Provide relief)
39
The slide displays PK data on both linear and log scales to demonstrate dose-related exposure and half-life characteristics.analyze_data
Open slide detailBeat · Solution (Provide relief)
40
The slide compares six different treatment arms across two scales to demonstrate dose-related exposure.analyze_data
Open slide detailBeat · Solution (Provide relief)
41
summarize
Open slide detailBeat · Solution (Provide relief)
42
Clinical trial update slide.present_framework
Open slide detailBeat · Solution (Provide relief)
43
The slide outlines the methodology for a clinical study, including target sample size (120) and duration (12 months).present_framework
Open slide detailBeat · Solution (Provide relief)
44
present_framework
Open slide detailBeat · Solution (Provide relief)
45
plan_implementation
Open slide detailBeat · Solution (Provide relief)
46
summarize
Open slide detailBeat · Solution (Provide relief)
47
plan_implementation
Open slide detailBeat · Solution (Provide relief)
48
summarize
Open slide detailBeat · Solution (Provide relief)
49
summarize
Open slide detail
50
summarize
Open slide detail
51
The slide uses a linear process flow with icons representing each stage.plan_implementation
Open slide detail
52
summarize
Open slide detail
53
other
Open slide detail